JAMA Internal Medicine · 2016 · 40 citations · 3 references
PharmacyPharmaceutical PolicyDrug Approval ProcessesPharmaceutical ManufacturingDrug ApprovalDrug EvaluationGeneric Drug EvaluationNew Drug ApplicationsPharmaceutical MarketingCoverage Of Brand-name DrugsGeneric Drug ApplicationsGeneric Drug Approval CriteriaGeneric Drug Approval PathwaysGeneric Drug MarketingHatch-waxman Act Applications
This study uses US Food and Drug Administration data to identify approved generic drugs manufactured between September 30, 1984, and January 11, 2016 and compares the effects of number of generic drugs associated with brand-name drugs.
3
IMS Institute for Healthcare Informatics
Roger G. Evans · Nursing Standard · 2014 · 604 citations
Public Affairs, Health Informatics, Health Services Administration +6
Generic Drug Industry Dynamics
David Reiffen, Michael R. Ward · The Review of Economics and Statistics · 2005 · 297 citations